Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2007 (Perampanel) Open-Label Extension in Parkinson's Disease
NCT00427011Phase 2Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2007
- Primary completion
- Apr 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perampanel in Parkinson's disease (PD), sponsored by Eisai Co., Ltd. Primary endpoint: Mean Change From Baseline by Visit in Absolute OFF Time at Week 56. Started Feb 2007; status: terminated.
02
Drugs
perampanel
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00427011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427011.